Correlation Between Anheuser Busch and Acumen Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anheuser Busch and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anheuser Busch and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anheuser Busch Inbev and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Anheuser Busch and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anheuser Busch with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anheuser Busch and Acumen Pharmaceuticals.

Diversification Opportunities for Anheuser Busch and Acumen Pharmaceuticals

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Anheuser and Acumen is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Anheuser Busch Inbev and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Anheuser Busch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anheuser Busch Inbev are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Anheuser Busch i.e., Anheuser Busch and Acumen Pharmaceuticals go up and down completely randomly.

Pair Corralation between Anheuser Busch and Acumen Pharmaceuticals

Considering the 90-day investment horizon Anheuser Busch Inbev is expected to under-perform the Acumen Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Anheuser Busch Inbev is 3.81 times less risky than Acumen Pharmaceuticals. The stock trades about -0.09 of its potential returns per unit of risk. The Acumen Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  275.00  in Acumen Pharmaceuticals on September 1, 2024 and sell it today you would lose (48.00) from holding Acumen Pharmaceuticals or give up 17.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Anheuser Busch Inbev  vs.  Acumen Pharmaceuticals

 Performance 
       Timeline  
Anheuser Busch Inbev 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anheuser Busch Inbev has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Acumen Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Acumen Pharmaceuticals is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Anheuser Busch and Acumen Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anheuser Busch and Acumen Pharmaceuticals

The main advantage of trading using opposite Anheuser Busch and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anheuser Busch position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.
The idea behind Anheuser Busch Inbev and Acumen Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities